Atlas Trials

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

Clinical trial NCT06075706 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06075706
Sponsor
medac GmbH
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Steroid-refractory Acute Graft-versus-host Disease
Start date
2023-11-13
Primary completion
2026-02-11
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.